ストックスクリーナーアプリを入手
1.26
0.94%
0.02
前日終値:
$1.24
開ける：
$1.27
24時間の取引高:
1.39M
Relative Volume:
0.32
時価総額：
$1.08B
収益：
$711.41M
当期純損益:
$-133.73M
株価収益率:
-6.6316
EPS:
-0.19
ネットキャッシュフロー:
$-199.99M
1週間 パフォーマンス:
-7.96%
1か月 パフォーマンス:
-11.54%
6か月 パフォーマンス:
-22.25%
1年 パフォーマンス:
-2.21%
1日の値動き範囲:
$1.25
$1.27
1週間の範囲:
$1.21
$1.355
52週間の値動き範囲:
$1.19
$2.035
Opko Health Inc Stock (OPK) Company Profile
OPK を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.255 | 1.08B | 711.41M | -133.73M | -199.99M | -0.19 |
|
TMO
Thermo Fisher Scientific Inc
|
431.17 | 159.40B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
199.25 | 141.27B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
507.99 | 38.21B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
115.13 | 30.90B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
155.86 | 26.35B | 15.50B | 1.33B | 2.16B | 7.34 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-25 | 開始されました | JP Morgan | Neutral |
| 2023-06-29 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2022-12-15 | 開始されました | H.C. Wainwright | Buy |
| 2022-01-24 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2021-06-21 | 開始されました | Ladenburg Thalmann | Buy |
| 2019-11-25 | 開始されました | Piper Jaffray | Overweight |
| 2018-03-02 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2017-09-14 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2016-06-21 | 繰り返されました | Standpoint Research | Buy |
| 2016-06-03 | 開始されました | Standpoint Research | Buy |
| 2016-03-31 | 繰り返されました | Barrington Research | Outperform |
| 2015-10-16 | 開始されました | JP Morgan | Overweight |
| 2015-09-11 | ダウングレード | Jefferies | Buy → Hold |
| 2015-03-03 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2014-05-12 | 繰り返されました | Oppenheimer | Outperform |
| 2014-03-14 | 開始されました | Oppenheimer | Outperform |
| 2013-11-13 | 繰り返されました | Ladenburg Thalmann | Buy |
| 2013-05-30 | 繰り返されました | Ladenburg Thalmann | Buy |
| 2012-10-22 | 開始されました | Barrington Research | Outperform |
| 2011-12-01 | 繰り返されました | Ladenburg Thalmann | Buy |
| 2011-07-14 | 開始されました | Ladenburg Thalmann | Buy |
すべてを表示
Opko Health Inc (OPK) 最新ニュース
Renaissance Technologies LLC Has $215,000 Position in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Voya Investment Management LLC Sells 815,679 Shares of OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) Shares Purchased by Barclays PLC - MarketBeat
Q2 Earnings Forecast for OPKO Health Issued By HC Wainwright - MarketBeat
Entera Bio Announces First Quarter 2025 Financial Results and Business Updates - The Manila Times
Clinical Laboratory Tests Market Top PlayersARUP - openPR.com
Secondary Hyperparathyroidism Treatment Market Grows with Rising CKD Cases | Amgen, Sanofi, OPKO Health - openPR.com
Opko health outlines $675M-$685M revenue guidance for 2025 amid strategic initiatives - MSN
Marshall Wace LLP Has $1.36 Million Position in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Invesco Ltd. Has $2.29 Million Stake in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Piper Sandler Keeps Their Buy Rating on Opko Health (OPK) - The Globe and Mail
OPKO Health, Inc. (NASDAQ:OPK) Q1 2025 Earnings Call Transcript - Insider Monkey
Weekly CEO Buys Highlight - GuruFocus
Labcorp Holdings Inc, BioReference Health, OPKO Health, Inc. - Olean Times Herald
OPKO Health, Inc. (NASDAQ:OPK) Short Interest Update - MarketBeat
OPKO Health’s Earnings Call: Mixed Sentiments and Strategic Moves - TipRanks
OPK Stock Slips Following Q1 Earnings Miss, Gross Margin Expands - Yahoo Finance
Quote - OPKO Health, Inc.
OPKO Health Inc (OPK) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial ... By GuruFocus - Investing.com Canada
OPKO Health (NASDAQ:OPK) Is Carrying A Fair Bit Of Debt - simplywall.st
OPKO Health Inc (OPK) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial ... - Yahoo Finance
Earnings call transcript: Opko Health misses Q1 2025 earnings forecast By Investing.com - Investing.com South Africa
OPKO Health Reports Q1 2025 Financial Highlights - TipRanks
OPKO Health: Q1 Earnings Snapshot - MySA
OPKO Health Inc Q1 2025 Earnings: EPS Misses at -$0.10, Revenue Falls Short at $149.9 Million - GuruFocus
OPKO Health (OPK) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
OPKO Health (OPK) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Earnings call transcript: Opko Health misses Q1 2025 earnings forecast - Investing.com
Opko Health earnings missed by $0.01, revenue fell short of estimates - Investing.com
OPKO Health Inc reports results for the quarter ended March 31Earnings Summary - TradingView
OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results - GlobeNewswire
OPKO Health Q1: $225M Oncology Asset Sale to Labcorp Plus New Oral GLP-1 Program Launch - Stock Titan
OPKO Health (NASDAQ:OPK) Now Covered by Analysts at JPMorgan Chase & Co. - MarketBeat
OPKO Health (OPK) to Release Earnings on Wednesday - MarketBeat
Pediatric Growth Hormone Deficiency Treatment Market Size - openPR.com
Press Release Distribution & PR Platform - ACCESS Newswire
JP Morgan Initiates Coverage of OPKO Health (OPK) with Neutral Recommendation - MSN
Analyst Expectations For OPKO Health's Future - Benzinga
JPMorgan starts Opko Health stock with Neutral rating By Investing.com - Investing.com India
This Rocket Lab Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday - Benzinga
Opko Health Inc (OPK) 財務データ
収益
当期純利益
現金流量
EPS
Opko Health Inc (OPK) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 08 '25 |
Buy |
1.48 |
125,000 |
184,650 |
213,876,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 01 '25 |
Buy |
1.65 |
100,000 |
164,850 |
213,751,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Mar 28 '25 |
Buy |
1.70 |
150,000 |
254,385 |
213,651,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Mar 17 '25 |
Buy |
1.74 |
200,000 |
347,820 |
213,501,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Feb 28 '25 |
Buy |
1.71 |
67,434 |
115,312 |
213,301,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 28 '25 |
Buy |
1.47 |
47,537 |
70,060 |
213,234,014 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 17 '25 |
Buy |
1.47 |
150,000 |
220,425 |
213,186,477 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 15 '25 |
Buy |
1.48 |
500,000 |
740,850 |
213,036,477 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Dec 13 '24 |
Buy |
1.59 |
125,000 |
199,375 |
212,536,477 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Dec 11 '24 |
Buy |
1.56 |
500,000 |
781,050 |
212,411,477 |
1.26%
1.09%
大文字化:
|
ボリューム (24 時間):